Search Results - "Ricardo Garcia‐Sanchez"

Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes by Rosenstock, Julio, Perl, Shira, Johnsson, Eva, García‐Sánchez, Ricardo, Jacob, Stephan

“…Aim To evaluate the efficacy and safety of triple therapy with low‐dose dapagliflozin plus saxagliptin added to metformin in uncontrolled type 2 diabetes…”
Get full text

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes by Müller‐Wieland, Dirk, Kellerer, Monika, Cypryk, Katarzyna, Skripova, Dasa, Rohwedder, Katja, Johnsson, Eva, Garcia‐Sanchez, Ricardo, Kurlyandskaya, Raisa, Sjöström, C. David, Jacob, Stephan, Seufert, Jochen, Dronamraju, Nalina, Csomós, Katalin

“…Objective To compare the efficacy and safety of dapagliflozin and dapagliflozin plus saxagliptin vs glimepiride as add‐on to metformin in patients with type 2…”
Get full text

Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes by Johansson, Lars, Hockings, Paul D., Johnsson, Eva, Dronamraju, Nalina, Maaske, Jill, Garcia‐Sanchez, Ricardo, Wilding, John P. H.

“…Aim To assess the effects of dapagliflozin plus saxagliptin plus metformin versus glimepiride plus metformin on liver fat (proton density fat fraction) and…”
Get full text

Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes by Handelsman, Yehuda, Mathieu, Chantal, Del Prato, Stefano, Johnsson, Eva, Kurlyandskaya, Raisa, Iqbal, Nayyar, Garcia‐Sanchez, Ricardo, Rosenstock, Julio

“…Aims To compare the efficacy and safety of an intensification strategy of early triple combination therapy with dapagliflozin (DAPA) plus saxagliptin (SAXA) to…”
Get full text

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post‐hoc analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin by Del Prato, Stefano, Rosenstock, Julio, Garcia‐Sanchez, Ricardo, Iqbal, Nayyar, Hansen, Lars, Johnsson, Eva, Chen, Hungta, Mathieu, Chantal

“…The safety of triple oral therapy with dapagliflozin plus saxagliptin plus metformin versus dual therapy with dapagliflozin or saxagliptin plus metformin was…”
Get full text

Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial by Frias, Juan P., Gonzalez‐Galvez, Guillermo, Johnsson, Eva, Maaske, Jill, Testa, Marcia A., Simonson, Donald C., Dronamraju, Nalina, Garcia‐Sanchez, Ricardo, Peters, Anne L.

“…Aims To evaluate the efficacy and safety of dapagliflozin (DAPA) + saxagliptin (SAXA) compared with glimepiride (GLIM) in patients with type 2 diabetes who…”
Get full text

Characteristics, interventions, and longer term outcomes of COVID‐19 ICU patients in Denmark—A nationwide, observational study by Haase, Nicolai, Plovsing, Ronni, Christensen, Steffen, Poulsen, Lone Musaeus, Brøchner, Anne Craveiro, Rasmussen, Bodil Steen, Helleberg, Marie, Jensen, Jens Ulrik Stæhr, Andersen, Lars Peter Kloster, Siegel, Hanna, Ibsen, Michael, Jørgensen, Vibeke, Winding, Robert, Iversen, Susanne, Pedersen, Henrik Planck, Madsen, Jacob, Sølling, Christoffer, Garcia, Ricardo Sanchez, Michelsen, Jens, Mohr, Thomas, Mannering, Anne, Espelund, Ulrick Skipper, Bundgaard, Helle, Kirkegaard, Lynge, Smitt, Margit, Buck, David Levarett, Ribergaard, Niels‐Erik, Pedersen, Helle Scharling, Christensen, Birgitte Viebæk, Perner, Anders

“…Background Most data on intensive care unit (ICU) patients with COVID‐19 originate in selected populations from stressed healthcare systems with shorter term…”
Get full text

Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study by Thomsen, Reimar Wernich, Nicolaisen, Sia Kromann, Hasvold, Pål, Garcia-Sanchez, Ricardo, Pedersen, Lars, Adelborg, Kasper, Egfjord, Martin, Egstrup, Kenneth, Sørensen, Henrik Toft

“…Data on the true burden of hyperkalemia in patients with heart failure (HF) in a real-world setting are limited. Incidence rates of hyperkalemia (first blood…”
Get full text

Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial by Vilsbøll, Tina, Ekholm, Ella, Johnsson, Eva, Garcia‐Sanchez, Ricardo, Dronamraju, Nalina, Jabbour, Serge A., Lind, Marcus

“…Aim Efficacy and safety of dapagliflozin plus saxagliptin (DAPA + SAXA) were compared with insulin glargine (INS) in patients with type 2 diabetes (T2D) in a…”
Get full text

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin by Rosenstock, Julio, Mathieu, Chantal, Chen, Hungta, Garcia-Sanchez, Ricardo, Saraiva, Gabriela Luporini

“…This analysis compared the efficacy and safety of the sodium-glucose cotransporter-2 (SGLT2) inhibitor, dapagliflozin, and the dipeptidyl peptidase-4 (DPP4)…”
Get full text

The patient's perspective of computerised records: a questionnaire survey in primary care by Garcia-Sanchez, Ricardo

“…The general practice consultation today has become a three-way process where patient, doctor and computer interact. Some studies have shown that the…”
Get full text

Quality of life and satisfaction with treatment in subjects with type 2 diabetes: Results in Spain of the PANORAMA study by DePablos-Velasco, Pedro, Salguero-Chaves, Emilio, Mata-Poyo, Julio, DeRivas-Otero, Beatriz, García-Sánchez, Ricardo, Viguera-Ester, Pablo

“…Abstract Objectives Few studies are available on quality of life and treatment satisfaction of patients with type 2 diabetes mellitus (T2DM). Both of them were…”
Get full text

Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study by Thomsen, Reimar W, Nicolaisen, Sia K, Hasvold, Pål, Sanchez, Ricardo Garcia, Pedersen, Lars, Adelborg, Kasper, Egstrup, Kenneth, Egfjord, Martin, Sørensen, Henrik Toft

“…Data on the true burden of hyperkalemia (HK) in patients with chronic kidney disease (CKD) in a real-world setting are scarce. The incidence rate of HK [first…”
Get full text

Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial by Vilsbøll, Tina, Ekholm, Ella, Johnsson, Eva, Ricardo Garcia‐Sanchez, Dronamraju, Nalina, Jabbour, Serge A, Lind, Marcus

“…AimEfficacy and safety of dapagliflozin plus saxagliptin (DAPA + SAXA) were compared with insulin glargine (INS) in patients with type 2 diabetes (T2D) in a…”
Get full text

Dapagliflozin plus Saxagliptin Add-On to Metformin Reduces Liver Fat and Adipose Tissue Volume in Patients with Type 2 Diabetes by WILDING, JOHN P., HOCKINGS, PAUL, JOHNSSON, EVA K., MAASKE, JILL, GARCIA-SANCHEZ, RICARDO, JOHANSSON, LARS

“…Oral administration of a fixed-dose combination of the SGLT2 inhibitor dapagliflozin (DAPA) and the DPP-4 inhibitor saxagliptin (SAXA) is approved for…”
Get full text

Cover Image, Volume 22, Issue 7 by Johansson, Lars, Hockings, Paul D., Johnsson, Eva, Dronamraju, Nalina, Maaske, Jill, Garcia‐Sanchez, Ricardo, Wilding, John P. H.

Get full text

Patient perceptions of their glycemie control and its influence on type 2 diabetes outcomes: an international survey of online communities by Simacek, Kristina, Curran, Christopher, Fenici, Peter, Garcia-Sanchez, Ricardo

“…Purpose: This study aimed to assess awareness of glycated hemoglobin (A1C) testing and targets, perceived level of glycemie control and risk of complications,…”
Get full text

Modulation of Dapagliflozin-Associated Genital Tract Infections by Saxagliptin—A Pooled Safety Analysis by PRATO, STEFANO DEL, JOHNSSON, EVA K., GARCIA-SANCHEZ, RICARDO, MORGAN, CLAIRE, SARTIPY, PETER, KURLYANDSKAYA, RAISA, IQBAL, NAYYAR, MATHIEU, CHANTAL

“…Incidence of genital tract infections (GTIs), a common adverse event during SGLT2 inhibitor therapy, may be modified by concomitant DPP-4 inhibitor treatment…”
Get full text

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: P ost‐hoc analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin by Del Prato, Stefano, Rosenstock, Julio, Garcia‐Sanchez, Ricardo, Iqbal, Nayyar, Hansen, Lars, Johnsson, Eva, Chen, Hungta, Mathieu, Chantal

“…The safety of triple oral therapy with dapagliflozin plus saxagliptin plus metformin versus dual therapy with dapagliflozin or saxagliptin plus metformin was…”
Get full text

Patient perceptions of their glycemic control and its influence on type 2 diabetes outcomes: an international survey of online communities by Simacek, Kristina, Curran, Christopher, Fenici, Peter, Garcia-Sanchez, Ricardo

“…This study aimed to assess awareness of glycated hemoglobin (A1C) testing and targets, perceived level of glycemic control and risk of complications, attitudes…”
Get full text